{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.28"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"341"}],"units":"Participants"}],"description":"The percentage of patients with abnormal results (Z ≤ -1.5) in executive function measured by CogState will be estimated.","groups":[{"description":"HR and VHR B-ALL patients, age 6 to \\<13 years who consented to participate in the CogState assessments.","id":"OG000","title":"HR and VHR B-ALL Patients (6 to <13 Years Old)"}],"paramType":"NUMBER","populationDescription":"It was pre-specified in Study Protocol to collect and report data as a single Arm/Group for patients who met eligibility criteria for this correlative aim . Inevaluable and ineligible patients were excluded from analysis.","reportingStatus":"POSTED","timeFrame":"Up to 10 years","title":"The Prevalence of Cognitive Deficits Measured by CogState (Domain: Executive Function), in Children (Ages 6 to < 13 Years) With HR- and VHR B-ALL at 1 Year Off Therapy","type":"SECONDARY","unitOfMeasure":"percentage of participants"}